会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • AEROSOLIZATION APPARATUS WITH CAPSULE PUNCTURE ALIGNMENT GUIDE
    • 胶囊矫正装置与胶囊针刺对准指南
    • WO2004091707A3
    • 2005-03-31
    • PCT/US2004011234
    • 2004-04-09
    • NEKTAR THERAPEUTICSDUNKLEY MICHAEL JOHNTUCKWELL JONATHAN DAVIDVERNON-HARCOURT EDWARD WILLIAMGLUSKER MARK JPABOOJIAN STEVE
    • DUNKLEY MICHAEL JOHNTUCKWELL JONATHAN DAVIDVERNON-HARCOURT EDWARD WILLIAMGLUSKER MARK JPABOOJIAN STEVE
    • A61M15/00
    • A61M15/0028A61M15/0033A61M2202/064
    • An aerosolization apparatus (100) comprises a housing (105) defining a chamber (110) having one or more air inlets (115) . The chamber is sized to receive a capsule (125) which contains an aerosolizable pharmaceutical formulation. The aerosolization apparatus further comprises a puncturing mechanism (130) within the housing. The puncturing mechanism comprises an alignment guide (132) and a puncture member (135), wherein the alignment guide comprises a surface (133) adapted to contact the capsule while the puncture member is advanced into the capsule to create an opening in the capsule. At least a portion of the surface is sloped relative to the longitudinal axis of the capsule. Alternatively or additionally, the surface may comprise one or more protrusions (300). An end section (140) is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the capsule through the opening created in the capsule. The alignment guide allows for more consistent puncturing of the capsule and a longer lifetime of the apparatus.
    • 雾化装置(100)包括限定具有一个或多个空气入口(115)的腔室(110)的壳体(105)。 该腔室的大小适于接收含有可雾化药物制剂的胶囊(125)。 雾化装置还包括在壳体内的穿刺机构(130)。 穿刺机构包括对准引导件(132)和穿刺构件(135),其中对准引导件包括适于在穿刺构件前进到胶囊中以接触胶囊的表面(133),以在胶囊中形成开口。 表面的至少一部分相对于胶囊的纵向轴线倾斜。 或者或另外,表面可以包括一个或多个突起(300)。 端部(140)与壳体相关联。 端部的尺寸和形状被容纳在使用者的嘴或鼻中,使得使用者可以通过端部部分吸入,以吸入通过在胶囊中形成的开口离开胶囊的雾化药物制剂。 对准引导件允许胶囊的更一致的穿刺和装置的更长的使用寿命。
    • 3. 发明专利
    • Flow resistance modulated aerosolized active agent delivery
    • 流动电阻调节的活性剂递送
    • JP2009136688A
    • 2009-06-25
    • JP2009002017
    • 2009-01-07
    • Nektar Therapeuticsネクター セラピューティックス
    • ANDREW CLARKESCHULER CARLOSPABOOJIAN STEVE
    • A61K9/12A61M15/00A61M11/00A61M16/00
    • A61M15/00A61M2016/0021A61M2202/064
    • PROBLEM TO BE SOLVED: To provide methods and devices for delivering an active agent formulation to the lung of a human patient, in which the active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant, and the active agent formulation is delivered to a patient at a low inspiratory flow rate for an initial period of time to increase bioavailability of the active agent.
      SOLUTION: The device 104 for delivering an active agent formulation to the lung of a human patient comprises a flow resistance modulator that modulates resistance to the flow of the aerosolized active agent formulation to produce an initial target flow rate of the aerosolized active agent formulation in a manner that is independent of patient instruction and flow rate monitoring 106.
      COPYRIGHT: (C)2009,JPO&INPIT
    • 要解决的问题:为了提供将活性剂制剂递送到人类患者的肺中的方法和装置,其中活性剂制剂可以是干粉形式,其可以是雾化的,或者可以是 与推进剂混合,并且活性剂制剂以低吸入流速在初始时期递送给患者以提高活性剂的生物利用度。 解决方案:用于将活性剂制剂输送到人类患者的肺的装置104包括流阻阻抗调节剂,其调节对雾化活性剂制剂的流动的阻力以产生雾化活性剂的初始目标流速 以不同于患者指导和流量监测106的方式进行制定。版权所有(C)2009年,JPO&INPIT